These findings suggest that CAP alleviates Aβ1–42 and tau-induced toxicity in AD model worms by enhancing antioxidant capacity through the activation of DAF-16 and SKN-1 signaling pathways. The gene discussed is MAPT; the disease is Alzheimer disease.